Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

RecruitingOBSERVATIONAL
Enrollment

1,100

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

September 20, 2041

Study Completion Date

May 1, 2042

Conditions
Myelodysplastic Syndromes
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH